SUPN
#1778
Supernus Pharmaceuticals, Inc. - Common Stock
47.3 5 USD
-0.02%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-2.29%
Monthly Change
+3.59%
6 month change
-9.24%
Year Change
-12.31%
Previous Close
48.4 6
Open
47.3 5
Low
47.3 5
High
47.3 5
Volume
66
Financials
- Market Capitalization 2.75 B
- Employee 778
- Founded 2005
- CEO Jack A. Khattar
- Website www.supernus.com
- Headquarter Delaware, United States
- FIGI BBG000BP0HX7
- Industry Drug Manufacturers—Specialty & Generic
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-73.09
Price to sales ratio
3.9
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1271 |  AMRX Amneal Pharmaceuticals, Inc. - Class A Common Stock | 17.18 USD | +1.00% | +0.29% | +5.53% | +62.84% | 5.48 B USD | ||
| 1359 |  INDV Indivior Pharmaceuticals, Inc. - Common Stock | 40.21 USD | -0.72% | +0.47% | +4.06% | +19.67% | 4.90 B USD | ||
| 1842 |  RGC Regencell Bioscience Holdings Limited - Ordinary Shares | 5.05 USD | -14.12% | -8.35% | -74.76% | -64.69% | 2.50 B USD | ||
| 1892 |  PBH Prestige Consumer Healthcare Inc. Common Stock | 48.89 USD | -0.14% | +0.60% | +2.93% | -36.71% | 2.32 B USD |
Frequently asked questions about Supernus Pharmaceuticals, Inc. - Common Stock
What is the Supernus Pharmaceuticals, Inc. - Common Stock stock price today?
The current price of Supernus Pharmaceuticals, Inc. - Common Stock (SUPN) is 47.35. Over the past 24 hours, the stock has changed by -2.29%. Follow the SUPN chart for real-time price dynamics.
What is the stock ticker of Supernus Pharmaceuticals, Inc. - Common Stock?
Supernus Pharmaceuticals, Inc. - Common Stock trades under the ticker SUPN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Supernus Pharmaceuticals, Inc. - Common Stock stock going up?
SUPN has changed by -0.80% over the last week, +3.59% over the last month, and -12.31% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Supernus Pharmaceuticals, Inc. - Common Stock net income for the last quarter?
Supernus Pharmaceuticals, Inc. - Common Stock reported net income of -2.29 M for the last quarter. The previous quarter showed -4.11 M, which means net income changed by +44.14%.
How many employees does Supernus Pharmaceuticals, Inc. - Common Stock have?
As of the latest available data, Supernus Pharmaceuticals, Inc. - Common Stock has 778 employees. Workforce size can provide additional context about the company's scale and operations.
What is Supernus Pharmaceuticals, Inc. - Common Stock EBITDA?
Supernus Pharmaceuticals, Inc. - Common Stock EBITDA is 17.8 M, and its EBITDA margin is 8.57%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Supernus Pharmaceuticals, Inc. - Common Stock stock?
You can buy Supernus Pharmaceuticals, Inc. - Common Stock (SUPN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Supernus Pharmaceuticals, Inc. - Common Stock stock?
Investing in Supernus Pharmaceuticals, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SUPN chart and related analysis on metatrader.com as part of your research.